JPS5444032A - Drug preparation for controlling prolactine secretion - Google Patents

Drug preparation for controlling prolactine secretion

Info

Publication number
JPS5444032A
JPS5444032A JP8953578A JP8953578A JPS5444032A JP S5444032 A JPS5444032 A JP S5444032A JP 8953578 A JP8953578 A JP 8953578A JP 8953578 A JP8953578 A JP 8953578A JP S5444032 A JPS5444032 A JP S5444032A
Authority
JP
Japan
Prior art keywords
prolactine
secretion
controlling
drug preparation
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8953578A
Other languages
Japanese (ja)
Inventor
Yuujin Harinton Furanshisu
Guren Babinton Ronarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/904,191 external-priority patent/US4202897A/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5444032A publication Critical patent/JPS5444032A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
JP8953578A 1977-07-25 1978-07-24 Drug preparation for controlling prolactine secretion Pending JPS5444032A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81842077A 1977-07-25 1977-07-25
US86236677A 1977-12-20 1977-12-20
US89129978A 1978-03-29 1978-03-29
US05/904,191 US4202897A (en) 1977-07-25 1978-05-11 Prolactin secretion inhibitors

Publications (1)

Publication Number Publication Date
JPS5444032A true JPS5444032A (en) 1979-04-07

Family

ID=27505854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8953578A Pending JPS5444032A (en) 1977-07-25 1978-07-24 Drug preparation for controlling prolactine secretion

Country Status (9)

Country Link
JP (1) JPS5444032A (en)
AU (1) AU3829978A (en)
DE (1) DE2830610A1 (en)
FR (1) FR2398499A1 (en)
GB (1) GB2001531A (en)
IL (1) IL55208A0 (en)
IT (1) IT7850363A0 (en)
NL (1) NL7807804A (en)
PH (1) PH15001A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012528105A (en) * 2009-05-27 2012-11-12 エム・エス・ディー・オス・ベー・フェー (Dihydro) imidazoiso (5,1-A) quinoline as an FSH receptor agonist for the treatment of fertility disorders

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853409A1 (en) * 1977-12-20 1979-06-21 Sandoz Ag ANTI-PARKINSON COMPOSITIONS
IT1215261B (en) * 1985-04-05 1990-01-31 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7117207A (en) * 1970-12-24 1972-06-27
FI370674A (en) * 1974-01-02 1975-07-03 Sandoz Ag

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012528105A (en) * 2009-05-27 2012-11-12 エム・エス・ディー・オス・ベー・フェー (Dihydro) imidazoiso (5,1-A) quinoline as an FSH receptor agonist for the treatment of fertility disorders

Also Published As

Publication number Publication date
PH15001A (en) 1982-03-22
IT7850363A0 (en) 1978-07-19
FR2398499A1 (en) 1979-02-23
AU3829978A (en) 1980-01-31
DE2830610A1 (en) 1979-02-08
FR2398499B1 (en) 1981-02-06
GB2001531A (en) 1979-02-07
IL55208A0 (en) 1978-09-29
NL7807804A (en) 1979-01-29

Similar Documents

Publication Publication Date Title
GB2003386B (en) Preparation for vaginal administration
JPS53146500A (en) Valve for prosthesis
GR64146B (en) Method for the preparation of new hydroxymethyl-5 oxazolidinones-2
GB1551706A (en) Surgical implant
GB1551704A (en) Surgical implant
JPS52151712A (en) Composition for medical preparation
AU3820378A (en) Programmable controller
JPS53136524A (en) Controlling agent for external zooparasite
GR65234B (en) Method for the preparation new cefalosporimical derivatives
GR65649B (en) Method for the preparation of 4-spectinomicilamine
GR64978B (en) Method for the preparation of bicyclical thia-diaza-compounds
JPS5440900A (en) Polydhosphazen for structure control
GR64093B (en) Method for the preparation of new aminoalkoxyphenyl-derivatives
JPS5490893A (en) Dental controller
GR65312B (en) Method for the preparation of thiazolidinodiones derivatives
GR64036B (en) Method for the preparation of substituted 1-phenyl-2-pyrrolidin-2-yl-ethanoles
PT68770A (en) Process for the preparation of powdered hydrated emulsifiers
GR64990B (en) Method for the preparation of aminoalcools
GR65025B (en) Method for the preparation of new imidazo-isokinolin-diones
JPS5444032A (en) Drug preparation for controlling prolactine secretion
ZA786259B (en) Therapeutic composition
GR64802B (en) Method for the preparation of 3-(tetrazol-5-gl)-1-azaxanthones
GR64924B (en) Method for the preparation of oxadiazole derivatives
GR64891B (en) Method for the preparation of derivatives of dis(nitrado-ureido)-polyles
GR65332B (en) Method for the preparation of new derivatives of fortimicine b